8-Bromo-1,2,3,5,6,7-hexahydro-s-indacen-4-amine, 97%, 5g

((1,3-Dichloropropan-2-yl)oxy)methyl acetate, 95.0%, 25g

2-((TERT-BUTOXYCARBONYL)AMINO)-2-(1-METHYL-1H-PYRAZOL-4-YL)ACETIC ACID, 95.0%, 100mg

5-AMINO-1-(3,5-DICHLORO-4-(4-CHLOROBENZOYL)BENZYL)-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE, 97%, 50mg

(R)-2-Amino-N-(4-methyl-2-oxo-2H-chromen-7-yl)propanamide 2,2,2-trifluoroacetate, 95%, 250mg

N-Acetyl-D-mannosamine, min. 98%, 1 g, glass packaging

1-Methylpyrrole-2-carboxaldehyde, 95.0%, 25g

N-methoxy-N-methyl-2-phenylquinoline-4-carboxamide, 95.0%, 2g

Ethyl 5-bromo-2-fluorobenzoate, 99.0%, 1g

{[1-(methylsulfonyl)-3-piperidinyl]methyl}amine, 95.0%, 500mg

Fmoc-(R)-3-Amino-4-(4-bromo-phenyl)-butyric acid, 98%, 250mg

2-Ethylhexylbromide, 97.0%, 500g

Dimethyl 2-(5-bromopyrimidin-2-yl)malonate, 95.0%, 25g